MedLink International to provide MedLink TotalOffice EHR as SaaS

MedLink International, Inc. (OTCBB: MLKNA) (OTCBB: MLKNAE) announced today that it will be providing the option of its MedLink TotalOffice EHR as a Software as a Service (SaaS) starting next month. The SaaS model will further assist providers to qualify for "meaningful use" by offering an affordable EHR framework to meet federal and state incentives for EHR adoption by reducing upfront hardware costs.

Ray Vuono, Chief Executive Officer of MedLink, stated, "We've seen a tremendous increase in interest in the MedLink EHR through some of the state and federal initiatives MedLink is involved in, that provide subsidies for the implementation and software costs associated with the purchase of an EHR. The SaaS model allows for practices to reduce the upfront investment in hardware and scale that investment into additional training and other services which ultimately will provide for a quicker ROI for the practice."

SaaS, also known as software "on demand," is a model in which software is developed, hosted and operated for use by customers over the Internet. The offering will help customers quickly and cost-effectively maximize the value of their EHR implementations by reducing the long term upfront investments in IT infrastructure.

Source:

MedLink International, Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
My personal journey with breast cancer and exploring spatial transcriptomics